Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001345281-25-000009
Filing Date
2025-06-20
Accepted
2025-06-20 14:12:14
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3877
  Complete submission text file 0001345281-25-000009.txt   5537
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2424 N FEDERAL HIGHWAY SUITE 208 BOCA RATON FL 33431
Business Address
DeSantis Damon (Reporting) CIK: 0001889279 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31668 | Film No.: 251060703